[Morphological substantiation of treatment of liver cirrhosis with retabolil].
The effect of retabolil on experimental liver cirrhosis in rats was studied. The results of the treatment point to a beneficial action of retabolil on the course of this malady, which found its expression in the prevalence regeneration manifestations over the processes of degeneration, as well as in the inhibitory effect on the development of liver cirrhosis. From morphometric investigations it follows that for retabolil the structure-target is the nucleonic system of the cells, largely of hepatocytes.
D045930:Anabolic Agents / Q000627:therapeutic use*; D000818:Animals; D002251:Carbon Tetrachloride / Q000009:adverse effects; D002467:Cell Nucleus / Q000187:drug effects; D003651:Decanoates / Q000627:therapeutic use; D008099:Liver / Q000187:drug effects / Q000473:pathology; D008103:Liver Cirrhosis / Q000139:chemically induced / Q000188:drug therapy*; D008115:Liver Regeneration; D008297:Male; D009277:Nandrolone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D051381:Rats
D045930:Anabolic Agents; D003651:Decanoates; D009277:Nandrolone; D002251:Carbon Tetrachloride
Morfologicheskoe obosnovanie lecheniia retabolilom tsirroza pecheni.